Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy

The purpose of this paper is to facilitate the comparison of magnetic resonance (MR) spectra acquired from unknown brain lesions with published spectra in order to help identify unknown lesions in clinical settings. The paper includes lists of references for published MR spectra of various brain dis...

Full description

Saved in:
Bibliographic Details
Published in:NMR in biomedicine 2006-06, Vol.19 (4), p.435-462
Main Authors: Kingsley, Peter B., Shah, Tanmaya C., Woldenberg, Rona
Format: Article
Language:English
Subjects:
Brain Neoplasms - diagnosis
Clinical Trials as Topic
Cryptococcus
Diagnosis, Computer-Assisted - methods
Evidence-Based Medicine
Human immunodeficiency virus
Humans
lymphoma
Magnetic Resonance Imaging - methods
Magnetic Resonance Spectroscopy - methods
propanediol
review
spectroscopy
Taenia
toxoplasmosis
Zellweger syndrome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of this paper is to facilitate the comparison of magnetic resonance (MR) spectra acquired from unknown brain lesions with published spectra in order to help identify unknown lesions in clinical settings. The paper includes lists of references for published MR spectra of various brain diseases, including pyogenic abscesses, encephalitis (herpes simplex, Rasmussen's and subacute sclerosing panencephalitis), neurocysticercosis, tuberculoma, cysts (arachnoid, epidermoid and hydatid), acute disseminated encephalomyelitis (ADEM), adrenoleukodystrophy (ALD), Alexander disease, Canavan's disease, Krabbe disease (globoid cell leukodystrophy), Leigh's disease, megalencephalic leukoencephalopathy with cysts, metachromatic leukodystrophy (MLD), Pelizaeus–Merzbacher disease, Zellweger syndrome, HIV‐associated lesions [cryptococcus, lymphoma, toxoplasmosis and progressive multifocal leukoencephalopathy (PML)], hydrocephalus and tuberous sclerosis. Each list includes information on the echo time(s) (TE) of the published spectra, whether a control spectrum is shown, whether the corresponding image and voxel position are shown and the patient ages if known. The references are listed in the approximate order of usefulness, based on spectral quality, number of spectra, range of echo times and whether the voxel positions are shown. Spectra of Zellweger syndrome, cryptococcal infection, toxoplasmosis and lymphoma are included, along with a spectrum showing propanediol (propylene glycol). Copyright © 2006 John Wiley & Sons, Ltd.
ISSN:0952-3480
1099-1492
DOI:10.1002/nbm.1039